# EDGAR Filing Document

**Accession Number:** 0001754195
**File Stem:** 0001754195-26-000043
**Filing Date:** 2026-6
**Character Count:** 6468
**Document Hash:** ada77e287a59ad45d7ca613480e70262
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001754195-26-000043.hdr.sgml**: 20260611

**ACCESSION NUMBER**: 0001754195-26-000043

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20260609

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260611

**DATE AS OF CHANGE**: 20260611

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Trulieve Cannabis Corp.
- **CENTRAL INDEX KEY:** 0001754195
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 581882476
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43338
- **FILM NUMBER:** 261081493

**BUSINESS ADDRESS:**
- **STREET 1:** 3494 MARTIN HURST ROAD
- **CITY:** TALLAHASSEE
- **STATE:** FL
- **ZIP:** 32312
- **BUSINESS PHONE:** 8502988866

**MAIL ADDRESS:**
- **STREET 1:** 3494 MARTIN HURST ROAD
- **CITY:** TALLAHASSEE
- **STATE:** FL
- **ZIP:** 32312

?xml version='1.0' encoding='ASCII'? tcnnf-20260609

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

____________________

**FORM 8-K**

___________________

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of Report (Date of Earliest Event Reported): June 9, 2026**

___________________

**TRULIEVE CANNABIS CORP.**

**(Exact Name of Registrant as specified in its charter)**

___________________

---

| | | |
|:---|:---|:---|
| **British Columbia** | **000-56248** | **84-2231905** |
| **(State or Other Jurisdiction**<br>**of Incorporation)** | **(Commission**<br>**File Number)** | **(IRS Employer**<br>**Identification No.)** |

---

**3494 Martin Hurst Road Tallahassee, FL 32312 (Address of principal executive offices and zip code) (850) 298-8866**

**(Registrant's telephone number, including area code)**

**Not Applicable**

**(Registrant's name or former address, if change since last report)** 

___________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br>**Symbol(s)** | **Name of each exchange**<br>**on which registered** |
| N/A | N/A | N/A |

---

------

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company □

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. □

**Item 5.07&nbsp;&nbsp;&nbsp;&nbsp;Submission of Matters to a Vote of Security Holders.**

The following are the voting results for the proposals considered and voted upon at the Meeting, each of which is described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 29, 2026.

**Proposal No. 1: To set the number of directors of the Company at seven (7)**

---

| | | |
|:---|:---|:---|
| **Votes For** | **Votes Against** | **Abstain** |
| 107,646,420 | 1,235,766 | 405,399 |

---

**Proposal No. 2: To elect seven directors as directors of the Company for the forthcoming year.**

The shareholders voted to elect the following individuals as directors of the Company until the next annual meeting of shareholders at which election of directors is considered, or until his or her successor is duly elected or appointed:

---

| | | | |
|:---|:---|:---|:---|
| **Name of Director Nominee** | **Votes For** | **Votes<br>Withheld** | **Broker<br>Non-Votes** |
| Matthew Foulston | 51696477 | 385925 | 57205183 |
| Peter Healy | 51392543 | 689859 | 57205183 |
| Richard May | 51395915 | 686487 | 57205183 |
| Thomas Millner | 51361433 | 720969 | 57205183 |
| Jane Morreau | 51425947 | 656455 | 57205183 |
| Kim Rivers | 49390466 | 2691936 | 57205183 |
| Susan Thronson | 48923343 | 3159059 | 57205183 |

---

**Proposal No. 3: To conduct a non-binding advisory vote on the compensation of the Company's named executive officers.**

The shareholders approved the compensation paid to the Company's named executive officers for the fiscal year ending December 31, 2025.

---

| | | | |
|:---|:---|:---|:---|
| **Votes For** | **Votes Against** | **Abstain** | **Broker<br>Non-Votes** |
| 49,752,239 | 1,997,073 | 333,090 | 57,205,183 |

---

**Proposal No. 4: To ratify the selection by the Audit Committee of the Board of WithumSmith+Brown, PC as auditors for the Company for the year ending December 31, 2026.**

The shareholders ratified the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the ensuing fiscal year ending December 31, 2026.

---

| | | |
|:---|:---|:---|
| **Votes For** | **Votes Against** | **Abstain** |
| 107,441,983 | 1,169,382 | 676,220 |

---

------

**Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.**

**(d) Exhibits**

---

| | |
|:---|:---|
| **Exhibit<br>No.** | **Description** |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| Trulieve Cannabis Corp. | Trulieve Cannabis Corp. |
| By: | /s/ Eric Powers |
| Name: | Eric Powers |
| Title: | Chief Legal Officer |

---

Date: June 11, 2026